Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386136986> ?p ?o ?g. }
- W4386136986 abstract "Abstract Immune checkpoint inhibitor treatment has the potential to prolong survival in non-small cell lung cancer (NSCLC), however, some of the patients develop resistance following initial response. Here, we analyze the immune phenotype of matching tumor samples from a cohort of NSCLC patients showing good initial response to immune checkpoint inhibitors, followed by acquired resistance at later time points. By using imaging mass cytometry and whole exome and RNA sequencing, we detect two patterns of resistance¨: One group of patients is characterized by reduced numbers of tumor-infiltrating CD8 + T cells and reduced expression of PD-L1 after development of resistance, whereas the other group shows high CD8 + T cell infiltration and high expression of PD-L1 in addition to markedly elevated expression of other immune-inhibitory molecules. In two cases, we detect downregulation of type I and II IFN pathways following progression to resistance, which could lead to an impaired anti-tumor immune response. This study thus captures the development of immune checkpoint inhibitor resistance as it progresses and deepens our mechanistic understanding of immunotherapy response in NSCLC." @default.
- W4386136986 created "2023-08-25" @default.
- W4386136986 creator A5003753570 @default.
- W4386136986 creator A5004143670 @default.
- W4386136986 creator A5008796552 @default.
- W4386136986 creator A5010642463 @default.
- W4386136986 creator A5014610359 @default.
- W4386136986 creator A5029846588 @default.
- W4386136986 creator A5038532092 @default.
- W4386136986 creator A5042767361 @default.
- W4386136986 creator A5051559340 @default.
- W4386136986 creator A5062674871 @default.
- W4386136986 creator A5062930299 @default.
- W4386136986 creator A5067512370 @default.
- W4386136986 creator A5068348080 @default.
- W4386136986 creator A5078378799 @default.
- W4386136986 creator A5087950206 @default.
- W4386136986 date "2023-08-24" @default.
- W4386136986 modified "2023-09-30" @default.
- W4386136986 title "Acquired resistance to anti-PD1 therapy in patients with NSCLC associates with immunosuppressive T cell phenotype" @default.
- W4386136986 cites W1426393029 @default.
- W4386136986 cites W1560312836 @default.
- W4386136986 cites W1571428739 @default.
- W4386136986 cites W1611944043 @default.
- W4386136986 cites W1753359669 @default.
- W4386136986 cites W1812517801 @default.
- W4386136986 cites W1854615013 @default.
- W4386136986 cites W1910012553 @default.
- W4386136986 cites W1968178474 @default.
- W4386136986 cites W1971208896 @default.
- W4386136986 cites W1971730021 @default.
- W4386136986 cites W1978436252 @default.
- W4386136986 cites W1982488143 @default.
- W4386136986 cites W1987165863 @default.
- W4386136986 cites W1987223917 @default.
- W4386136986 cites W1999740664 @default.
- W4386136986 cites W2016789384 @default.
- W4386136986 cites W2028182878 @default.
- W4386136986 cites W2037342985 @default.
- W4386136986 cites W2040327758 @default.
- W4386136986 cites W2041143310 @default.
- W4386136986 cites W2052313621 @default.
- W4386136986 cites W2063557805 @default.
- W4386136986 cites W2064297038 @default.
- W4386136986 cites W2073084242 @default.
- W4386136986 cites W2075006354 @default.
- W4386136986 cites W2079018735 @default.
- W4386136986 cites W2086831568 @default.
- W4386136986 cites W2097855813 @default.
- W4386136986 cites W2101653483 @default.
- W4386136986 cites W2103441770 @default.
- W4386136986 cites W2104347254 @default.
- W4386136986 cites W2104479723 @default.
- W4386136986 cites W2106511606 @default.
- W4386136986 cites W2106747061 @default.
- W4386136986 cites W2107598346 @default.
- W4386136986 cites W2109485845 @default.
- W4386136986 cites W2111381709 @default.
- W4386136986 cites W2123895023 @default.
- W4386136986 cites W2124427232 @default.
- W4386136986 cites W2128758225 @default.
- W4386136986 cites W2136731993 @default.
- W4386136986 cites W2138601221 @default.
- W4386136986 cites W2141196759 @default.
- W4386136986 cites W2142169541 @default.
- W4386136986 cites W2143488876 @default.
- W4386136986 cites W2146290346 @default.
- W4386136986 cites W2148590804 @default.
- W4386136986 cites W2149121521 @default.
- W4386136986 cites W2155033435 @default.
- W4386136986 cites W2155879201 @default.
- W4386136986 cites W2155943701 @default.
- W4386136986 cites W2159707944 @default.
- W4386136986 cites W2166662937 @default.
- W4386136986 cites W2168244200 @default.
- W4386136986 cites W2179438025 @default.
- W4386136986 cites W2180481128 @default.
- W4386136986 cites W2216675461 @default.
- W4386136986 cites W2275249553 @default.
- W4386136986 cites W2299181842 @default.
- W4386136986 cites W2329974159 @default.
- W4386136986 cites W2345879537 @default.
- W4386136986 cites W2419528132 @default.
- W4386136986 cites W2465860350 @default.
- W4386136986 cites W2524088453 @default.
- W4386136986 cites W2560367415 @default.
- W4386136986 cites W2568773821 @default.
- W4386136986 cites W2570618306 @default.
- W4386136986 cites W2572174216 @default.
- W4386136986 cites W2578528809 @default.
- W4386136986 cites W2581179619 @default.
- W4386136986 cites W2587048937 @default.
- W4386136986 cites W2592144107 @default.
- W4386136986 cites W2603526557 @default.
- W4386136986 cites W2604777432 @default.
- W4386136986 cites W2621003511 @default.
- W4386136986 cites W2622499649 @default.
- W4386136986 cites W2736476343 @default.
- W4386136986 cites W2743344672 @default.
- W4386136986 cites W2744743363 @default.